Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Marie Cleton-Jansen

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Nuclear Medicine and Biology|October 19, 2006
Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studiesCelia Maria Freitas Gomes, Heidi van Paassen, Salvatore Romeo, et al.
Molecular Cancer Research : MCR|September 2, 2017
NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for ChondrosarcomaElisabeth F P Peterse, Brendy E W M van den Akker, Bertine Niessen, et al.
BMC Medical Genomics|September 22, 2011
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenograftsMarieke L Kuijjer, Heidi M Namløs, Esther I Hauben, et al.
Plos One|November 13, 2012
Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcomaStine H Kresse, Halfdan Rydbeck, Magne Skårn, et al.
Clinical Sarcoma Research|June 5, 2019
Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genesYvonne de Jong, Martha Ingola, Inge H Briaire-de Bruijn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2007
Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibiCélia M F Gomes, Mick Welling, Ivo Que, et al.
Cancer|August 6, 2013
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation studyChiara Colombo, Rosalba Miceli, Alexander J Lazar, et al.
Genes & Cancer|January 26, 2016
MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylationZuzanna Baranski, Tijmen H Booij, Marieke L Kuijjer, et al.
Journal of Cellular Physiology|September 3, 2015
Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and KLF4Sara R Martins-Neves, Willem E Corver, Daniela I Paiva-Oliveira, et al.
BMC Cancer|April 18, 2008
ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphismAnne-Marie Cleton-Jansen, Ronald van Eijk, Marcel Lombaerts, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Nuclear Medicine and Biology|October 19, 2006
Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studiesCelia Maria Freitas Gomes, Heidi van Paassen, Salvatore Romeo, et al.
Molecular Cancer Research : MCR|September 2, 2017
NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for ChondrosarcomaElisabeth F P Peterse, Brendy E W M van den Akker, Bertine Niessen, et al.
BMC Medical Genomics|September 22, 2011
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenograftsMarieke L Kuijjer, Heidi M Namløs, Esther I Hauben, et al.
Plos One|November 13, 2012
Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcomaStine H Kresse, Halfdan Rydbeck, Magne Skårn, et al.
Clinical Sarcoma Research|June 5, 2019
Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genesYvonne de Jong, Martha Ingola, Inge H Briaire-de Bruijn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2007
Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibiCélia M F Gomes, Mick Welling, Ivo Que, et al.
Cancer|August 6, 2013
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation studyChiara Colombo, Rosalba Miceli, Alexander J Lazar, et al.
Genes & Cancer|January 26, 2016
MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylationZuzanna Baranski, Tijmen H Booij, Marieke L Kuijjer, et al.
Journal of Cellular Physiology|September 3, 2015
Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and KLF4Sara R Martins-Neves, Willem E Corver, Daniela I Paiva-Oliveira, et al.
BMC Cancer|April 18, 2008
ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphismAnne-Marie Cleton-Jansen, Ronald van Eijk, Marcel Lombaerts, et al.
Pageof 13